Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $211.97 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $199.76 | 2 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $12.21 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $12.21 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($12.21) |
| 2019 | $182.26 | 1 | Boston Scientific Corporation ($182.26) |
| 2018 | $17.50 | 1 | BOSTON SCIENTIFIC CORPORATION ($17.50) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/03/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: Gastroenterology | ||||||
| 10/15/2019 | Boston Scientific Corporation | GENERAL THERAPIES (Device) | Food and Beverage | In-kind items and services | $182.26 | General |
| Category: THERAPIES | ||||||
| 03/08/2018 | BOSTON SCIENTIFIC CORPORATION | SPYGLASS (Device) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: BILIARY DEVICES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 602 | 691 | $314,270 | $74,707 |
| 2022 | 11 | 593 | 688 | $287,565 | $75,434 |
| 2021 | 14 | 631 | 782 | $265,785 | $81,261 |
| 2020 | 17 | 658 | 1,602 | $447,765 | $115,129 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 179 | 217 | $59,675 | $21,198 | 35.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 89 | 89 | $31,150 | $10,991 | 35.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 48 | 49 | $63,700 | $10,637 | 16.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 59 | 108 | $14,040 | $7,007 | 49.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 43 | 43 | $10,535 | $4,594 | 43.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 28 | $9,800 | $3,926 | 40.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 49 | 49 | $47,285 | $3,918 | 8.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 33 | 33 | $39,600 | $3,628 | 9.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 17 | 17 | $14,705 | $2,889 | 19.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 15 | 15 | $12,975 | $2,741 | 21.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $8,525 | $2,279 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 12 | $2,280 | $897.72 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 203 | 269 | $61,915 | $25,804 | 41.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 117 | 117 | $37,290 | $15,089 | 40.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 38 | 38 | $49,400 | $8,018 | 16.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 34 | 36 | $10,985 | $5,296 | 48.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 21 | 21 | $17,535 | $3,978 | 22.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 45 | 45 | $43,425 | $3,847 | 8.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 35 | 56 | $7,280 | $3,290 | 45.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 32 | 32 | $38,400 | $3,223 | 8.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 39 | 39 | $9,195 | $2,779 | 30.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 17 | 23 | $9,200 | $2,762 | 30.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $2,940 | $1,349 | 45.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 185 | 281 | $53,825 | $28,242 | 52.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 82 | 128 | $16,640 | $7,618 | 45.8% |
About Dr. Martin Chatzinoff, M.D
Dr. Martin Chatzinoff, M.D is a Gastroenterology healthcare provider based in Rydal, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205883659.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Martin Chatzinoff, M.D has received a total of $211.97 in payments from pharmaceutical and medical device companies, with $12.21 received in 2021. These payments were reported across 3 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($211.97).
As a Medicare-enrolled provider, Chatzinoff has provided services to 2,484 Medicare beneficiaries, totaling 3,763 services with total Medicare billing of $346,531. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Rydal, PA
- Active Since 05/30/2006
- Last Updated 01/10/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1205883659
Products in Payments
- GENERAL THERAPIES (Device) $182.26
- SPYGLASS (Device) $17.50
- XIFAXAN (Drug) $12.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Rydal
Dr. Stuart Lubinski, M.d, M.D
Gastroenterology — Payments: $14,743
Dr. Cesar Delatorre, M.d, M.D
Gastroenterology — Payments: $2,877
Dr. Daniel Ringold, M.d, M.D
Gastroenterology — Payments: $2,130
Dr. Julia Binder, Md, MD
Gastroenterology — Payments: $1,099
Christina Brown, M.d, M.D
Gastroenterology — Payments: $1,072
Dr. Eric Goosenberg, M.d, M.D
Gastroenterology — Payments: $971.79